D
ermoscopy is a non-invasive diagnostic procedure that allows the visualization of structures located in the epidermis, dermoepidermal junction and papillary dermis, that normally cannot be seen with the naked eye (1) . Dermoscopy was first introduced for diagnosis and evaluation of skin tumors and melanomas, and gradually has become a commonly used skin cancer screening tool. (2) . Nowadays, digital dermoscopy follow-up has gained ground for the monitoring of patients especially those with multiple and atypical moles.
The traditional dermoscopic criteria of melanoma have been investigated and established in the context of superficial spreading melanoma (SSM). SSM is the most common and the easiest to recognize type of melanoma. However, it might be difficult to detect in early stages.
Dermoscopic features of SSM include atypical pigment network, irregular dots or globules, irregular streaks and regression structures ( Figure 1 ) (3, 4) . Asymmetric pigmentation pattern, asymmetric shape, irregular blotches, blue-white veil and a multicomponent global pattern can also be observed (4 -6) . An atypical vascular pattern of linear irregular vessels, dotted vessels, or milky-red areas are also a common finding (4 -6).
Sadayasu et al. suggested the presence of a sudden change of the intralesional color, from a blue-gray structureless area in the center to a peripheral lightbrown pigment network, as a diagnostic indicator of melanomas (3) .
The aforementioned melanoma criteria have been tested in several studies and showed valid for melanoma diagnosis. Based on these criteria, several dermoscopic algorithms have been created (ABCD rule, 7-point checklist, Menzies method). However, melanomas on specific body sites, melanomas in patients with multiple atypical moles, and nodular melanomas often lack the "traditional" melanoma criteria, rendering their recognition particularly troublesome.
This paper aims to summarize recent advances on the dermoscopic patterns of difficult-to-diagnose melanomas.
Dermoscopy allows clinicians to detect morphological characteristics of melanomas that precede the appearance of clinical symptoms (7) . AM is dermoscopically characterized by a multicomponent pattern, a parallel ridge pattern, irregular diffuse pigmentation (also called blotches), milky-red areas, peripheral dots and globules, and an abrupt peripheral margin ( Figure 2 ) (8) . It has to be noted that, besides the dermoscopic patterns, clinicians should always take into account the maximum diameter of the acral lesions. Saida et al. and Braun et al. observed that lesions with a diameter >7 mm and >1 cm, respectively, are more likely to be melanomas, regardless of dermoscopic characteristics (9) (10) (11) 8) .
As for the subungual melanoma, dermoscopic criteria include light to dark brown coloration of the background, the lines are barely visible, brown to black longitudinal lines, the color, spacing and the width are irregular, parallelism and Hutchinson's sign (periungual pigmentation) ( Figure 3 ) (12, 13).
Lallas et al. developed the BRAAFF scoring system for the detection of AM without nail-apparatus melanoma. The dermoscopic variables include four positive predictors (irregular blotches, parallel ridge pattern, asymmetry of structures, asymmetry of colors) and two negative predictors (parallel furrow pattern, fibrillary pattern). The authors highlighted that these variables should always be counted in the Serbian Journal of Dermatology and Venereology 2016; 8 (3): [121] [122] [123] [124] [125] [126] [127] overall clinical context of the patient and recommend histopathological examination in equivocal cases (14) .
Mucosal melanoma
Although dermoscopy is widely used in the diagnosis of pigmented and nonpigmented lesions of the skin, its role in the evaluation of pigmented mucosal lesions is not well established. The two largest studies referring to dermoscopy of pigmented mucosal lesions were conducted by Lin et al. (15) and the International Dermoscopy Society (IDS) (16) , and included 40 and 140 pigmented mucosal cases, respectively, from lips, penis, vulva and other anogenital areas.
According to the results of the first study, asymmetry of structure, multiple colors, blue-white veil and irregular dots/globules are the commonest features in mucosal melanoma compared with the findings of benign lesions. In the second study, a combination of at least 1 of 3 colors (blue, gray or white) with structureless zones was shown to have a relatively high diagnostic accuracy when differentiating between benign and malignant lesions. Moreover, authors noted that multiple colors outmatch the multiple patterns. Finally, the presence of structureless parts and gray color may be indicative of early stages of mucosal melanomas (MM). On the contrary, multiple patterns and additional colors, especially blue or white, seem to be more indicative of late MM stages. (17, 18) were the first to propose a progression model for LMM that includes four dermoscopic criteria: asymmetrical pigmented follicular openings, dark rhomboidal structures, slate-gray dots forming an annular-granular pattern, and slate-gray globules (Figure 4 ). The combination of these features showed a sensitivity of 89% and a specificity of 96% in the diagnosis of LMM. Furthermore, light brown fingerprint areas and horny pseudocysts were indicated as features representing benign growths.
Later, Pralong et al. (19) studied 125 cases and noted that at least one of the four 4 SchiffnerStolz criteria were present in 87% of lesions, and further described four additional criteria: mainly vascular -increased density of the vascular network, red rhomboidal structures, target-like patterns and darkening at dermoscopic examination (when compared with naked-eye examination).
Tschandl et al. (20) analyzed dermatoscopy images of 240 flat pigmented facial skin lesions and claimed that a pattern of circles is highly suggestive for LMM, while the presence of gray color strengthens the diagnosis. Finally, Lallas et al. (21) , attempted to differentiate facial LMM from PAK, and conducted a study of 144 lesions with LMM, PAK and SL/SK and created a scoring scheme for LMM diagnosis; a total score of ≥ 1 has a sensitivity of 92.9% and a specificity of 55.4% for the diagnosis of LMM. Furthermore, the absence of evident follicles (the follicular openings within the pigmented lesion are not clearly visible and obvious and are obscured by pigmentation of any color) in combination with gray rhomboidal lines are suggestive of LMM and biopsy is required.
Nodular melanoma
Nodular melanoma (NM) is a rapidly progressing neoplasm with a high risk for metastasis, even in its early stages (22, 23) . NM lacks an initial radial growth phase, presenting with a vertical growth (22) . Furthermore, it lacks the commonly used ABCD criteria (asymmetry, border irregularity, color variegation, diameter ≥ 6mm), while, dermoscopically, NM displays no "traditional" melanoma-specific criteria. For these reasons, the EFG Figure 2 . An acral melanoma dermoscopically typified by a parallel ridge pattern and asymmetry of colors and structures melanocytic lesions. A multivariate analysis showed that asymmetric pigmentation, blue-black pigmented areas, homogeneous disorganized pattern, a combination of polymorphous vessels and milky red globules/areas or red homogeneous areas, significantly increased the risk of NM ( Figure 5 ). On the other hand, homogeneous pattern was found to be a positive factor for nonmelanocytic and benign melanocytic lesions. Finally, ulcerations, homogeneous disorganized patterns, and homogeneous blue pigmented structureless areas, are features favoring a NM diagnosis, in contrast with peripheral light brown structureless areas which advocate in favor of SSM.
Melanomas in patients with multiple nevi
It has been demonstrated that dermoscopy is more accurate than naked eye examination for melanoma detection (26, 27) . However, in patients with multiple atypical nevi, dermoscopy might be inadequate to uncover a melanoma among a plethora of clinically and dermoscopically atypical moles (28) . A high number of melanocytic nevi is considered to be a major risk factor for melanoma (29, 30) . Given that melanoma can sometimes be misdiagnosed as a nevus, the diagnosis of the malignancy among patients with more than 50 common nevi in total, or multiple clinically 'atypical' or 'dysplastic' moles (referring to diagnostic uncertainty of being a melanoma) is very challenging. Subsequently, early melanoma detection and reduction of unnecessary excisions is of utmost importance. The most effective strategy to manage these patients includes clinical and dermoscopic examination of all lesions, in order to identify the 'signature nevus pattern' of each patient (comparative approach). The comparative approach is based on the observation that the majority of an individual's nevi display similar dermoscopic characteristics, while melanoma deviates this "signature pattern" (31) (32) (33) . Another suggested strategy for the management of these patients includes the use of digital dermoscopy monitoring of melanocytic lesions, based on the fact that benign lesions stay stable while melanomas change over time (34) .
Meta-analytic data of digital dermoscopy followup (DDF) of melanocytic skin lesions (35) , suggested that DDF is a reliable method for the detection of early melanomas, while maintaining a reasonably low rate of excisions of benign moles. Specifically, more than half of excised melanomas in patients under DDF were in situ and, among invasive tumors, none was thicker than 1 mm. It was also noted that longer follow-up period was related with the diagnosis of more melanomas. Therefore, one can assume that close surveillance, rule (Elevation, Firmness on palpation, continuous Growth over one month) has been introduced in clinical practice in the diagnosis of NM.
Several studies attempted to examine and propose dermoscopic features for NM recognition. Argenziano et al, (24) proposed the blue-black rule, that is blue (usually structureless) and black (dots, globules, blotches) areas involving at least 10% of the lesion surface, as a significant indicator of NM. The blue color corresponds to pigmented melanocytes in the deep dermis, while black arises from intraepidermal melanin or from dense dermal proliferation of pigmented melanocytes under a thinned epidermis, usually due to ulceration (25) . The combination of the blue-black feature and one or more of the standard melanoma criteria has a 84.6 % sensitivity and 80.5 % specificity.
In 2015, Pizzichetta et al. (5) studied 457 pigmented skin lesions in order to describe dermoscopic characteristics of pigmented NM, compared with SSM and pigmented nodular non melanocytic and benign (36) noted that not only long-but also short-term dermoscopy monitoring is highly effective for melanoma detection in patients with multiple atypical nevi.
The International Dermoscopy Society (37), suggested two different strategies of follow-up based on the number of lesions. When clinicians face a suspicious lesion in a patient with a single or a few lesions, an excision or a 2 to 4 month monitoring period should follow. If the lesion is benign, no further examination is needed. The second strategy is suggested for patients with multiple lesions, where a comparative approach should be first applied (with a possible excision of the most atypical lesion). Consequently, a follow-up (of flat reticular lesions only) should be first scheduled after a 3-month interval following the baseline visit, and then after a 6 -12 month interval. Εlevated equivocal lesions with significant regression should not be monitored but excised because of the possibility of being invasive melanomas. Finally, it has to be stated that patients' compliance was found to be optimized by short-rather than long-term intervals between the visits (38) .
Conclusion
Dermoscopy is considered to be an integral part of clinical examination for the evaluation and detection of melanoma. Recent advances in the morphological evaluation of melanomas, changing the "traditional" criteria, enhance recognition of melanomas that might otherwise escape detection. As more studies are performed and new data are gathered, clinicians should always update their knowledge in order to minimize the risk of missing a melanoma. 
